The Integration of Mass Spectrometry to the Process Development of Fusion Protein Therapeutics
Speaker Presentation Shao Chun, Bristol-Myers Squibb Company, 2021
The Integration of Mass Spectrometry to the Process Development of Fusion Protein Therapeutics
The Integration of Mass Spectrometry to the Process Development of Fusion Protein Therapeutics